Other studies suggested that inhibition of CDK4 plays an important role in hepatic fatty acid metabolism in reducing CCAAT-enhancer-binding proteins (C/EBPα)/ histone acetyltransferase p300 complexes and eliminating hepatic steatosis [39]. Here, CDK4 is linked to fatty liver disease.